Bain Capital Life Sciences Investors LLC grew its position in shares of Annexon, Inc. (NASDAQ:ANNX – Free Report) by 41.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,061,719 shares of the company’s stock after buying an additional 2,359,793 shares during the period. […]
Bain Capital Life Sciences Investors LLC grew its position in shares of Annexon, Inc. (NASDAQ:ANNX – Free Report) by 41.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,061,719 shares of the company’s stock after buying an additional 2,359,793 shares during the period. […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]
Rhenman & Partners Asset Management AB decreased its position in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Pliant Therapeutics were worth $2,042,000 […]
DLD Asset Management LP acquired a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,000 shares of the company’s stock, valued at approximately $223,000. DLD Asset Management LP owned about […]